Showing 1 - 10 of 46
BDMS Partners Advance Holistic Care for Breast Cancer Patients
Published on 12/12/2025
» As efforts to improve breast cancer care continue to evolve, Bangkok Cancer Hospital Wattanosoth is strengthening its commitment to patient well-being through its concept “Care Beyond Cure – Beyond the Cure, Our Care Never Ends.” Introduced in line with Breast Cancer Awareness Month this October, the initiative delivers comprehensive support that extends far beyond medical treatment, helping patients and their families regain balance, confidence, and quality of life at every stage. This approach is further reinforced by the hospital’s adoption of ICHOM standards (International Consortium for Health Outcomes Measurement), which focus on enhancing outcomes and overall life quality from diagnosis through long-term follow-up.
Patients to gain cancer drug access
News, Post Reporters, Published on 04/12/2025
» The government has approved new reimbursement rules enabling patients with advanced non-small cell lung cancer (NSCLC) to use targeted therapies, Erlotinib or Gefitinib, as first-line treatment, effective for medical expenses incurred from Dec 1 onwards.
Thai influenza cases surge past 700,000 with 61 deaths
Komsan Jandamit, Published on 09/10/2025
» Thailand’s Department of Disease Control has sounded the alarm over a sharp rise in influenza cases, which have now surpassed 700,000 nationwide, with 61 deaths reported.
Chula Licenses Thai PD-1 Antibody to US Biopharma
Published on 06/08/2025
» Bangkok, August 6, 2025 — Chulalongkorn University has entered a landmark licensing agreement with US-based biopharmaceutical company OncoSynergy Inc., transferring the technology behind its innovative Thai-developed PD-1 antibody that could offer new hope in advancing next-generation cancer immunotherapy.
Thailand produces its first targeted cancer drug
Post Reporters, Published on 11/07/2025
» Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of the scientific vision and leadership of Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana.
Thainakarin Earns AACI Accreditation for Oncology Excellence
Published on 27/06/2025
» Thainakarin Hospital has officially received certification from the American Accreditation Commission International (AACI) for Clinical Oncology Services Excellence—marking a significant milestone in the hospital’s mission to become a leading specialised cancer care centre.
Weed policy shift gets thumbs-down
News, Chairith Yonpiam, Published on 17/06/2025
» Three years after Thailand became the first country in Asia to decriminalise cannabis, health and civil society experts are raising concerns over public health and inadequate regulations which accompanied the move.
Hospital sees breakthrough in stem cell transplant for cancer
News, Apinya Wipatayotin, Published on 02/05/2025
» Rajavithi Hospital has successfully performed its first stem cell transplantation on a patient diagnosed with multiple myeloma (MM), a form of cancer, marking a significant milestone in the hospital's efforts to advance life-saving medical technologies.
Mahidol Launches Fund for Thailand's First 'Living Drug' Facility
News, Published on 29/01/2025
» Mahidol University, in collaboration with the Mahidol University Foundation under the Royal Patronage of Her Royal Highness Princess Maha Chakri Sirindhorn, has launched a transformative initiative to redefine Thailand's medical landscape.
Cancer treatment reimbursement changes postponed
News, Post Reporters, Published on 25/12/2024
» The National Health Security Office (NHSO) has deferred the launch of new budget reimbursement criteria for hospitals joining the Cancer Treatment Anywhere (CA) programme pending discussions to deal with reimbursement shortcomings.